lobbying_activities: 1845668

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1845668	4f105781-93fe-4805-9a18-5482e42d2935	Q2	EMERGENT BIOSOLUTIONS INC.	304931	EMERGENT BIOSOLUTIONS INC	2016	second_quarter	MED	H.R.4400 and S 2512 - Adding Zika Virus to the FDA Priority Review Program Act - entire bill	HOUSE OF REPRESENTATIVES,SENATE		1300000	0	0	2016-07-18T11:38:23.773000-04:00